[
    [
        {
            "time": "2023-10-01",
            "original_text": "净利润虚增千万！华大基因收行政监管措施决定书 欺诈造假",
            "features": {
                "keywords": [
                    "净利润",
                    "虚增",
                    "华大基因",
                    "行政监管",
                    "欺诈造假"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "净利润虚增千万！华大基因收行政监管措施决定书 欺诈造假",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "华大基因相关收入核算不规范 遭深圳证监局责令改正 其他违规处罚",
            "features": {
                "keywords": [
                    "华大基因",
                    "收入核算",
                    "不规范",
                    "深圳证监局",
                    "责令改正"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因相关收入核算不规范 遭深圳证监局责令改正 其他违规处罚",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "内控不规范华大基因遭监管“爆锤”：多计净利润1234万 向关联方“输血”0.31亿 关联方问题",
            "features": {
                "keywords": [
                    "内控",
                    "华大基因",
                    "监管",
                    "爆锤",
                    "多计净利润",
                    "关联方",
                    "输血"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "内控不规范华大基因遭监管“爆锤”：多计净利润1234万 向关联方“输血”0.31亿 关联方问题",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "因财务漏洞多计利润 华大基因收行政监管措施决定书 其他违规处罚",
            "features": {
                "keywords": [
                    "财务漏洞",
                    "多计利润",
                    "华大基因",
                    "行政监管",
                    "违规处罚"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "因财务漏洞多计利润 华大基因收行政监管措施决定书 其他违规处罚",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "问题一箩筐 净利润虚增千万 华大基因收整改书 欺诈造假",
            "features": {
                "keywords": [
                    "问题",
                    "净利润",
                    "虚增",
                    "华大基因",
                    "整改书",
                    "欺诈造假"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "问题一箩筐 净利润虚增千万 华大基因收整改书 欺诈造假",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "公告精选：中国银行拟发行优先股募资不超过1000亿元；万达信息获中国人寿增持3.98%股份；华大基因收入核算不规范收到监管函",
            "features": {
                "keywords": [
                    "中国银行",
                    "优先股",
                    "万达信息",
                    "中国人寿",
                    "华大基因",
                    "收入核算",
                    "不规范",
                    "监管函"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "公告精选：中国银行拟发行优先股募资不超过1000亿元；万达信息获中国人寿增持3.98%股份；华大基因收入核算不规范收到监管函",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "华大基因:公司订单型收入确认依赖的系统存在漏洞 经营问题",
            "features": {
                "keywords": [
                    "华大基因",
                    "订单型收入",
                    "系统漏洞",
                    "经营问题"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因:公司订单型收入确认依赖的系统存在漏洞 经营问题",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "华大基因：收到深圳证监局行政监管措施决定书 其他违规处罚",
            "features": {
                "keywords": [
                    "华大基因",
                    "深圳证监局",
                    "行政监管",
                    "违规处罚"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因：收到深圳证监局行政监管措施决定书 其他违规处罚",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]